Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: The STRAMBO study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages

  Schoppet, M ^a   Hofbauer, L C ^b   Brinskelle Schmal, N ^c   Varennes, A ^d   Goudable, J ^e   Richard, M ^d   Hawa, G ^f,g   Chapurlat, R ^e   Szulc, Pawel ^e  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^c Biomarker Design Forschungs GmbH   (Austria)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e UNIVERSITÉ DE LYON   (France)

^f BioMedica   (Austria)

^g Technopolmanager Krems ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM; CREATININE; ESTRADIOL; FIBROBLAST GROWTH FACTOR 23; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE; TESTOSTERONE;

ABDOMINAL AORTIC CALCIFICATION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE METABOLISM; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; GLOMERULUS FILTRATION RATE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MINERAL METABOLISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FIBROBLAST GROWTH FACTORS; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PREVALENCE; SEVERITY OF ILLNESS INDEX; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84859555836     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2836     Document Type: Article

References (64)

1. Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen NL, Michaëlsson K 2009 Cardiovascular diseases and risk of hip fracture. JAMA 302:1666-1673
2. Szulc P, Kiel DP, Delmas PD 2008 Calcifications in the abdominal aorta predict fractures in men: MINOS study. J Bone Miner Res 23:95-102
3. Naves M, Rodríguez-García M, Díaz-Ló pez JB, Gó mez-Alonso C, Cannata-Andía JB 2008 Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int 19:1161-1166
4. van Diepen S, Majumdar SR, Bakal JA, McAlister FA, Ezekowitz JA 2008 Heart failure is a risk factor for orthopedic fracture: a population- based analysis of 16,294 patients. Circulation 118:1946-1952
5. Collins TC, Ewing SK, Diem SJ, Taylor BC, Orwoll ES, Cummings SR, Strotmeyer ES, Ensrud KE 2009 Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation 119:2305-2312
6. Szulc P, Samelson EJ, Kiel DP, Delmas PD 2009 Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res 24:2023-2031
7. Wiklund P, NordströmA, Jansson JH, Weinehall L, Nordström P 20 April 2011 Low bone mineral density is associated with increased risk for myocardial infarction in men and women. Osteoporos Int 10.1007/s00198-011-1631-0
8. Tankó LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR 2005 Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912-1920 (Pubitemid 41532776)
9. Nordström A, Eriksson M, Stegmayr B, Gustafson Y, Nordström P 2010 Low bone mineral density is an independent risk factor for stroke and death. Cerebrovasc Dis 29:130-136
10. Bagger YZ, Tankó LB, Alexandersen P, Qin G, Christiansen C 2006 Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259:598-605
11. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS 1998 Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268 (Pubitemid 28213402)
12. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G 1997 Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81 (Pubitemid 27130923)
13. Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, Kostenuik PJ, Erben RG, Hofbauer LC 2009 Inhibition of receptor activator of NF-≲καππα∀B ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol 175:473-478
14. Hori M, Shimizu Y, Fukumoto S 2011 Fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. Endocrinology 152:4-10
15. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568 (Pubitemid 38542505)
16. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M 2006 Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120-6123 (Pubitemid 43847540)
17. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI 1997 Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51 (Pubitemid 27494749)
18. Bai X, Miao D, Li J, Goltzman D, Karaplis AC 2004 Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145:5269-5279 (Pubitemid 39551149)
19. Dalal M, Sun K, Cappola AR, Ferrucci L, Crasto C, Fried LP, Semba RD 2011 Relationship of fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women. Eur J Endocrinol 165:797-803
20. Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH 2010 The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 152:640-648
21. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M 2008 Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584-592
22. Taylor EN, Rimm EB, Stampfer MJ, Curhan GC 2011 Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 161:956-962
23. Mirza MA, Larsson A, Lind L, Larsson TE 2009 Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205:385-390
24. Mirza MA, Hansen T, Johansson L, Ahlström H, Larsson A, Lind L, Larsson TE 2009 Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant 24:3125-3131
25. Balci M, Kirkpantur A, Gulbay M, Gurbuz OA 2010 Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int 14:425-432
26. Ashikaga E, Honda H, Suzuki H, Hosaka N, Hirai Y, Sanada D, Nakamura M, Nagai H, Matsumoto K, Kato N, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T 2010 Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients. Ther Apher Dial 14:315-322
27. Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y 2006 Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int 17:1506-1513 (Pubitemid 44387485)
28. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C 2009 Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 24:948-955
29. Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA 2010 Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 25:2679-2685
30. Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA 23 November 2011 FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 10.1007/s00198-011-1838-0
31. Roos M, Lutz J, Salmhofer H, Luppa P, Knauss A, Braun S, Martinof S, Schömig A, Heemann U, Kastrati A, Hausleiter J 2008 Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) 68:660-665 (Pubitemid 351388700)
32. Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW 1997 New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132:245-250 (Pubitemid 27311017)
33. Wilson PW, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA 2001 Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103:1529-1534 (Pubitemid 32226260)
34. Schousboe JT, Wilson KE, Hangartner TN 2007 Detection of aortic calcification during vertebral fracture assessment (VFA) compared to digital radiography. PLoS One 8:e715
35. McCloskey EV, Vasireddy S, Threlkeld J, Eastaugh J, Parry A, Bonnet N, Beneton M, Kanis JA, Charlesworth D 2008 Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis. J Bone Miner Res 23:1561-1568
36. Schousboe JT, Taylor BC, Kiel DP, Ensrud KE, Wilson KE, McCloskey EV 2008 Abdominal aortic calcification detected on lateral spine images from a bone densitometer predicts incident myocardial infarction or stroke in older women. J Bone Miner Res 23:409-416 (Pubitemid 351304671)
37. Bolland MJ, Wang TK, van Pelt NC, Horne AM, Mason BH, Ames RW, Grey AB, Ruygrok PN, Gamble GD, Reid IR 2010 Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J Bone Miner Res 25:505-512
38. Chaitou A, Boutroy S, Vilayphiou N, Munoz F, Delmas PD, Chapurlat R, Szulc P 2010 Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study. J Bone Miner Res 25:2313-2323
39. Chaitou A, Boutroy S, Vilayphiou N, Varennes A, Richard M, Blaizot S, Munoz F, Delmas PD, Goudable J, Chapurlat R, Szulc P 2011 Association of bone microarchitecture with parathyroid hormone concentration and calcium intake in men: the STRAMBO study. Eur J Endocrinol 165:151-159
40. Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD 2003 Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Calcif Tissue Int 73:520-530 (Pubitemid 37517796)
41. Szulc P, Hawa G, Boutroy S, Vilayphiou N, Schoppet M, Chapurlat R, Hofbauer LC 2011 Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. J Clin Endocrinol Metab 96:2216-2226
42. Szulc P, Uusi-Rasi K, Claustrat B, Marchand F, Beck TJ, Delmas PD 2004 Role of sex steroids in the regulation of bone morphology in men. The MINOS study. Osteoporos Int 15:909-917 (Pubitemid 39506458)
43. Szulc P, Debiesse E, Boutroy S, Vilauphiou N, Chapurlat R 2011 Poor trabecular microarchitecture in male current smokers: the cross-sectional STRAMBO study. Calcif Tissue Int 89:303-311
44. Bacchetta J, Boutroy S, Vilayphiou N, Juillard L, Guebre-Egziabher F, Rognant N, Sornay-Rendu E, Szulc P, Laville M, Delmas PD, Fouque D, Chapurlat R 2010 Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res 25:849-857
45. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J 2009 A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612
46. Ketteler M, Biggar PH 2009 Getting the balance right: assessing causes and extent of vascular calcification in chronic kidney disease. Nephrology 14:389-394
47. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM 2008 Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 73:384-390 (Pubitemid 351186286)
48. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS 2007 Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879-885 (Pubitemid 46762749)
49. Frazão JM, Adragaõ T 2008 Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data. Kidney Int Suppl 111:S38-S43
50. Larsson T, Yu X, Davis SI, Draman MS, Mooney SD, Cullen MJ, White KE 2005 A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 90:2424-2427 (Pubitemid 40586293)
51. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, WangTJ, deFilippi C, Wolf M 2009 Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545-2552
52. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M 2011 FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393-4408
53. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J 2003 Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827-833 (Pubitemid 36331846)
54. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C 2005 Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25:1629-1633 (Pubitemid 41098932)
55. Cranenburg EC, Brandenburg VM, Vermeer C, Stenger M, Mühlenbruch G, Mahnken AH, Gladziwa U, Ketteler M, Schurgers LJ 2009 Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients.Thromb Haemost 101:359-366
56. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y 2002 Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106:1192-1194 (Pubitemid 34988634)
57. Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC 2003 Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 88:1024-1028 (Pubitemid 36337751)
58. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J 2004 Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109:2175-2180 (Pubitemid 38625393)
59. Kato K, Jeanneau C, Tarp MA, Benet-Pagès A, Lorenz-Depiereux B, Bennett EP, Mandel U, Strom TM, Clausen H 2006 Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 281:18370-18377 (Pubitemid 44035494)
60. Larsson T, Davis SI, Garringer HJ, Mooney SD, Draman MS, Cullen MJ, White KE 2005 Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology 146:3883-3891 (Pubitemid 41178968)
61. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS 2009 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20:1805-1812
62. Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM 2010 Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 95:E352-E357
63. Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, Shuto E, Nashiki K, Arai H, Yamamoto H, Takeda E 2006 Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70:2141-2147 (Pubitemid 44871378)
64. Kemi VE, Kärkkäinen MU, Lamberg-Allardt CJ 2006 High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J Nutr 96:545-552